Abbott LaboratoriesvsiRadimed

ABT and IRMD stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.45

Value $187B

-0.99%
ABT's page

IRMD

iRadimed Corporation

$84.84

Value $1.1B

-0.60%
IRMD's page

Abbott Laboratories (ABT) has a market value of $187B and iRadimed (IRMD) $1.1B. Over the last year, with dividends, ABT moved -15.7% and IRMD +2.0%. The P/E is 39.7 for ABT and 45.2 for IRMD. Dividend yield: ABT 2.35%, IRMD 0.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    IRMD$1.1B

    ABT is 172 times IRMD

  • Revenue, 12 months

    ABT$48.2B

    IRMD$89M

    ABT is 540 times IRMD

  • Net income, 12 months

    ABT$4.7B

    IRMD$24M

    ABT is 196 times IRMD

  • Operating margin

    ABT13.8%

    IRMD32.3%

    18.5 points apart

  • ROIC

    ABT6.3%

    IRMD22.3%

    16.0 points apart

  • P/E

    ABT39.7

    IRMD45.2

    IRMD is 1.1 times ABT

  • Dividend yield

    ABT2.4%

    IRMD0.9%

    1.5 points apart

  • 5-year return

    ABT-8.3%

    IRMD+135.4%

    143.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.3%

IRMD+135.4%

10020020222023202420252026
Returns by period
PeriodABTWith dividendsIRMDWith dividends
1 year since November 14, 2025-15.7%Price -17.7%+2.0%Price +0.6%
3 years since November 16, 2023+14.2%+4.5% a yearPrice +7.2%+110.2%+28.1% a yearPrice +100.3%
5 years since November 15, 2021-8.3%-1.7% a yearPrice -17.0%+135.4%+18.7% a yearPrice +113.6%
10 years since November 16, 2016+224.5%+12.5% a yearPrice +169.0%+753.8%+23.9% a yearPrice +674.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesIRMDiRadimed

Valuation

ABTIRMD
Valuation
Price$107.45$84.84
Market value$187B$1.1B
Enterprise value (EV)$214B$1.0B
P/E39.745.2
P/E, 5-year median33.736.7
P/B3.710.2
EV/EBIT32.135.4
Free cash flow yield3.6%2.4%

Results and growth

ABTIRMD
Results and growth
Revenue, 12 months$48.2B$89M
Net income, 12 months$4.7B$24M
Free cash flow, 12 months$6.8B$26M
Earnings per share, 12 months$2.69$1.87
Revenue growth, year on year5.7%14.4%
Revenue growth a year, past+5.1%over 5 years+21.5%over 5 years
EPS growth a year, past+8.3%over 5 years+73.9%over 5 years

Margins and returns on capital

ABTIRMD
Margins and returns on capital
Gross margin56.9%75.5%
Operating margin13.8%32.3%
Net margin9.8%26.9%
ROIC6.3%22.3%
ROE9.1%24.0%

Balance sheet

ABTIRMD
Balance sheet
Cash$4.3B$63M
Total debt$31.2B–
Net debt / EBITDA3.3–
Interest cover6.7×–

Dividends and buybacks

ABTIRMD
Dividends and buybacks
Dividend yield2.4%0.9%
Dividend per share, 12 months$2.52$0.80
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.8%0.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or IRMD

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or iRadimed?

By market value, Abbott Laboratories ($187B) is about 172.2 times iRadimed ($1.1B), at today's prices.

How did ABT and IRMD stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +169.0% and IRMD's +674.8%. With dividends: ABT +224.5% (+12.5% a year), IRMD +753.8% (+23.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or IRMD?

The dividend yield at today's price is 2.35% for Abbott Laboratories and 0.94% for iRadimed. Over the last twelve months they paid $2.52 and $0.80 per share.

What is the P/E of ABT and IRMD?

At today's price, the P/E is 39.7 for ABT and 45.2 for IRMD. The median of the last five years was 33.7 and 36.7, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or iRadimed?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 26.9% for iRadimed, and the operating margin 13.8% and 32.3%. Revenue was $48.2B and $89M.

Which is the better investment, Abbott Laboratories or iRadimed?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.